Direct Acting Antiviral Medicines Market Grow with a High CAGR Global Industry Analysis, Key Manufacturers, Trends, Size, and Forecast 2029
Research Nester released a report titled “Direct-Acting Antiviral Medicines Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global direct-acting antiviral medicines market in terms of market segmentation by drug class type, end-user and region.
The direct-acting
antiviral medicines market is projected to grow with a moderate
CAGR during the forecast period, i.e., 2021-2029 on account of the rising prevalence
of liver cirrhosis and hepatocellular carcinoma and the increasing investment
in the development of advanced therapies. According to the World Health Organization (WHO), nearly 71
million people are living with chronic hepatitis C virus infection. Of these, a
large group of population developed cirrhosis or liver cancer. Additionally, in
2016, nearly 399,000 people died from hepatitis C.
The
market is segmented by drug class type into NS3/4A protease inhibitors, NS5A polymerase inhibitors, NS5B polymerase inhibitors, and combination drugs. Among these segments, the combination drugs segment is anticipated to hold the largest
share by the end of 2021 in the direct-acting antiviral medicines market as
a result of being considered as an appropriate medicine for treatment of liver
diseases in a large number of clinical trials. On the basis of end-user, the
market is segmented into hospital pharmacies, retail pharmacies, and others.
On the
basis of region, the market is segmented into North America, Europe, Asia
Pacific, Latin America, and the Middle East & Africa, out of which, the direct-acting
antiviral medicines market in the Asia Pacific is projected to
grow at the highest CAGR throughout the forecast period. Currently, the market
in North America holds the largest share. This can be attributed to the
presence of leading healthcare providers in the region, accompanied by high
awareness about direct-acting antiviral medicines in the region.
Get Exclusive Sample
Report Copy Of This Report @
https://www.researchnester.com/sample-request-3005
Increasing Prevalence of Liver Cirrhosis
and Hepatocellular Carcinoma and Growing Investment in the Development of
Advanced Therapies to Drive Market Growth
According
to the Global Burden of Disease Study, in 2017, liver cirrhosis caused more
than 1.32 million deaths globally which constituted 2.4% of the total global
deaths in 2017.
Chronic
alcohol use is one of the most predominant risk factors for liver cirrhosis. It
has been observed that individuals who consume high quantities of alcohol on a
regular basis possess a high risk of having liver cirrhosis. Additionally, the
rising prevalence of chronic viral infections of the liver in recent years is
also expected to boost the market growth in upcoming years. However, poor access to direct-acting
antiviral medicines in low income regions and side effects of direct-acting
antiviral medicines are some of the factors that are estimated to
restrain market growth in the near future.
This report also provides the existing competitive scenario of some of the key players of the global direct-acting antiviral medicines market which includes company profiling of AbbVie, Inc. (NYSE: ABBV), Janssen Therapeutics, Bristol-Myers Squibb (NYSE: BMY), Merck & Co. (NYSE: MRK), Vertex Pharmaceuticals (NASDAQ: VRTX), Johnson & Johnson (NYSE: JNJ), Gilead Sciences, Inc. (NASDAQ: GILD), Natco Pharma (NSE: NATCOPHARM), and Dr. Reddy’s Laboratories (NSE: DRREDDY). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global direct-acting antiviral medicines market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Comments
Post a Comment